NL-OMON31229CompletedNot Applicable
Activating the frontal brain in schizophrenia: comparison of aripiprazole versus resperidone using functional magnetic resonance imaging - MRI study on the effect of Abilify versus Risperdal
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 44
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18 to 99 (—)
Inclusion Criteria
- •People diagnozed for schizophrenia according to DSM-IV. They should not repsond to first choiche treatment or suffer from serious side effects.
- •Besides, healthy control without high education level.
Exclusion Criteria
- •Subjects with a psychiatric or neurologic disease other than schizophrenia, for which they have been treated. Presence of MRI incompatible implants. For safety reasons female participants who may be pregnant will be excluded.
Investigators
Similar Trials
Completed
Not Applicable
Prefrontal Cortical Engagement Through Non-Invasive Brain Stimulation in SchizophreniaPsychosisSchizophreniaNCT02975973Baylor College of Medicine15
Not yet recruiting
Not Applicable
Functional MRI study for altruism of schizophrenic patientschizophreniaJPRN-UMIN000009952Department of Psychiatry, School of Medicine, Showa University60
Completed
Not Applicable
eural network changes in schizophrenia10039628schizophreniaNL-OMON35397niversitair Medisch Centrum Utrecht410
Not yet recruiting
Not Applicable
treatment for schizophrenia patients: double-blind randomized controlled trial studySchizophreniaIRCT20210608051514N2Zanjan University of Medical Sciences40
Completed
Not Applicable
Investigation for frontal function in psychiatric disorder, by using functional near-infrared spectroscopy.Psychiatric disordersJPRN-UMIN000024000Keio University School of Medicine, Department of Neuropsychiatry80